Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | H1₹25.21Accepted-AOC | ₹25.21 | H1 | Accepted-AOC H1 Rates |
| 2 | H2₹25.17Rejected-Finance | ₹25.17 | H2 | Rejected-Finance Rejected because of H2 Rates. |
| 3 | H3₹21.21Rejected-Finance | ₹21.21 | H3 | Rejected-Finance Rejected because of H3 Rates. |
| Sl No | Description | Qty | Unit | M/S JANSEWA CHEMIST H1 | BHAWNA MEDICAL AGENCIES H3 | Nova Brothers / Twangdhwaj Singh H2 |
|---|---|---|---|---|---|---|
| 0.00CKMP | ||||||
| 1.00 | SUPPLY OF CANCER , KIDNEY, MONOPOLY, PATENT MEDICINES ON DISCOUNTED RATE ON MRP FOR ESIS UJJAIN CENTER ( PLEASE ENTER BELOW PERCENTAGE ON MRP) | 1 | Nos | 25.21 ₹25.21 | 21.21 ₹21.21 Lowest | 25.17 ₹25.17 |
Tender Value
Refer Docs
EMD Value
₹1 L
Closing Date
13 Apr 2026, 5:30 pmClosed
DIRECTOR ESIS INDORE
DIRECTORATE, ESIS, NANDA NAGAR INDORE MP
CKMP MEDICINE TENDER
2026_ESI_489916_3
5627/2026-27/UJJAIN/CKMP
Open Tender
Medicines
Percentage
1 days
UJJAIN
AS PER NIT
5 documents required · 5 mandatory
₹2,000
₹1 L
10 Jun 2026
6 Apr 2026
15 Apr 2026
6 Apr 2026
13 Apr 2026
6 Apr 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 0 | CKMP | - | - | - | - |
| 1 | SUPPLY OF CANCER , KIDNEY, MONOPOLY, PATENT MEDICINES ON DISCOUNTED RATE ON MRP FOR ESIS UJJAIN CENTER ( PLEASE ENTER BELOW PERCENTAGE ON MRP) | - | Nos | - | - |
stage.html
html • 0.04 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 2.05 MB
UJJAIN.pdf
Tender Documents • 2.03 MB
Doc.pdf
Other Document • 0.53 MB
BOQ_598180.xls
BOQ • 0.23 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].